Fibrinogen Anomalies and Disease
- 1 October 1992
- journal article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 6 (5) , 1171-1187
- https://doi.org/10.1016/s0889-8588(18)30303-4
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Anticoagulant Albumin Fragments That Bind to Fibrinogen/Fibrin: Possible ImplicationsSeminars in Thrombosis and Hemostasis, 1992
- A glycosaminoglycan inhibitor of thrombin: A new mechanism for abnormal hemostatic assays in cancerAmerican Journal of Hematology, 1991
- Delayed intermolecular ??-chain cross-linking by factor XIIIa in fibrinogen Asahi characterized by a ??-Met-310 to Thr substitution with an N-glycosylated ??-Asn-308Blood Coagulation & Fibrinolysis, 1990
- Pathologic Fibrinolysis as a Cause of Clinical BleedingSeminars in Thrombosis and Hemostasis, 1990
- Fibrinogen giessen I: A congenital homozygously expressed dysfibrinogenemia with Aα 16 Arg← his substitutionAmerican Journal of Hematology, 1987
- COVALENT STRUCTURE OF FIBRINOGENAnnals of the New York Academy of Sciences, 1983
- FIBRINOGEN LOUISVILLE: AN Aα16 ARG→HIS DEFECT THAT FORMS NO HYBRID MOLECULES IN HETEROZYGOUS INDIVIDUALS AND INHIBITS AGGREGATION OF NORMAL FIBRIN MONOMERS*Annals of the New York Academy of Sciences, 1983
- Idiopathic autoantibody that inhibits fibrin monomer polymerizationBritish Journal of Haematology, 1983
- A Naturally Occurring Antibody That Inhibits Fibrin PolymerizationNew England Journal of Medicine, 1981
- Dysfibrinogenemia Associated with HepatomaNew England Journal of Medicine, 1978